Zaire Ebola vaccine candidates

South Korea's GC Biopharma Corp. announced on Thursday that its flu vaccine GC Flu secured a $10 million order in the upcoming bid by Thailand's Gov...

The Korea Advanced Institute of Science & Technology (KAIST) announced on Thursday that it signed a memorandum of understanding (MOU) with the I...

South Korea's SK Bioscience Co. announced on Wednesday that it signed a business agreement with the international non-profit research organization H...

South Korea’s VaxCell Biotherapeutics Co. (VaxCell-Bio) on Tuesday announced its application for approval for Vaxleukin-15, an anti-cancer dru...

South Korean biotech company Curocell Inc. on Sunday said it will apply for approval from the Ministry of Food and Drug Safety in September next yea...

South Korea’s Humedix Co., a developer of biological and pharmaceutical products, on Tuesday said it received approval from the Ministry of Fo...

South Korean vaccine developer Quratis Inc. on Wednesday announced its signing of a term sheet on the direction and major transaction terms of coope...

South Korea’s Ildong Pharmaceutical Co. will spin off its research and development (R&D) unit into the subsidiary Yunovia from Nov. 1.&nbs...

Genome & Company, a South Korean developer of microbiome-based drugs, on Tuesday said its GEN-001, a leading immunotherapy drug candidate for bi...

South Korea's Daewoong Pharmaceutical is venturing into the development of a product that can easily treat diabetic retinopathy in the form of ...

Hanmi Science Co., the holding company of South Korea’s pharmaceutical giant Hanmi Pharmaceutical Co., has joined the global race to develop t...

South Korea’s top-tier contract drugmaker Genuone Sciences Inc. with an estimated value of up to 1 trillion won ($752 million) is smooth saili...

Wellmarker Bio, South Korea's oncology drug development company, announced on Monday that it has signed a technology transfer agreement with a Europ...

KB Financial Group Inc. has chosen Yang Jong-hee, its vice chairman, as the sole candidate for its next chief in charge of South Korea’s leadi...

South Korea's Yungjin Pharm has secured Fast Track designation from the US Food and Drug Administration (FDA) for its new drug candidate KL1333, des...

A drug candidate in South Korea could allow people seeking to lose weight to eat to their heart's content.The Center for Cognition and Sociality of ...

South Korea's EuBiologics Co., the world's leading cholera vaccine company, has signed a joint production agreement with GC Biopharma Corp. to produ...

POSCO International Corp., the general trading and energy exploration unit of South Korea's steel giant POSCO Holdings Inc., announced on Thursday t...

SK Bioscience Co., the drug-making unit of South Korea’s SK Group, on Wednesday shipped SKYCellflu, its vaccine for the common flu, for the fi...

South Korea's Hanmi Pharmaceutical Co. announced on Tuesday that it has received approval for the phase 1 clinical trial plan of the immune-oncology...

SK Bioscience Co., the drug-making unit of South Korea’s SK Group, announced on Monday that it has signed a deal with Thailand's state-owned G...

Japanese insurer Tokio Marine Holdings Inc. is seeking to sell its units in Southeast Asia for $1 billion to major South Korean companies looking fo...

South Korea's Qurient Co. announced on Monday that it signed a research and development agreement with the US government agency National Cancer Inst...

South Korea's LG Chem Ltd. will produce the nation's first homegrown six-in-one vaccine for infants, something that the country is entirely reliant ...

South Korea's GC Biopharma Corp. announced on Wednesday that its quadrivalent influenza vaccine "GC Flu Quadrivalent" has received approval from Egy...

South Korea’s SK Biopharmaceuticals Co. is aiming to triple its enterprise value to $15 billion by 2026 with the goal of rising to the top run...

Prestige Biopharma, a Singapore-based biopharmaceutical company with operations in South Korea and the US, announced on Tuesday that it will partici...

EcoPro Co., Hanwha Ocean Co., JYP Entertainment Corp. and Kumyang Co. are the top candidates for inclusion in the MSCI Korea Index when the global s...

South Korea’s GI Innovation Inc. aims to complete licensing of its allergic diseases treatment candidate to a Japanese drug company by year's ...

SK Bioscience Co., the drug-making unit of South Korea’s SK Group, announced on Wednesday that it has signed a memorandum of understanding (MO...